Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Human embryonic stem (hES) cell lines are of great potential in cell transplantation therapy. However, recipients of such allogeneic transplants probably need treatment with immunosuppressants. Recently, Taylor et al. [Lancet 2005;366:2019-2025] proposed banking of hES cell lines and estimated the required number of hES cell lines for beneficial human leukocyte antigen (HLA) matching in the U.K. population. Here, we carried out such an estimation in the Japanese population. We calculated the proportion of patients who can find at least one HLA-matched donor at three loci of HLA-A, -B, and -DR. With a bank of hES cell lines from 170 randomly selected donated embryos, 80% of patients were expected to find at least one hES cell line with a single mismatch at one HLA locus or a better match. Furthermore, 80% of patients are expected to find at least one donor with complete matching at the three HLA loci if parthenogenetic homozygous hES cell lines are established from 55 randomly selected donated oocytes. The relatively low ethnic diversity of the Japanese population may have resulted in a high success rate in beneficial matching. Moreover, parthenogenetic hES cell lines can greatly reduce the number required for a higher degree of HLA matching.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, an HLA iPSC bank with iPSCs derived from 55 donors can be used to perform iPSC-based cell therapy for 80% of the Japanese population, a country with limited HLA variability [106].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [106]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
Taylor, C. J., Bolton, E. M., Pocock, S., Sharples, L. D., Pedersen, R. A., & Bradley, J. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67813-0 · Cited by 493
Petersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., & Hansen, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3515 · Cited by 480
Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0188 · Cited by 402
Parthenogenetic Stem Cells in Nonhuman Primates
Cibelli, J. B., Grant, K. A., Chapman, K. B., Cunniff, K., Worst, T., Green, H. L., Walker, S. J., Gutin, P. H., Vilner, L., Tabar, V., et al. (2002) · Science · doi:10.1126/science.1065637 · Cited by 311
Suemori, H., Yasuchika, K., Hasegawa, K., Fujioka, T., Tsuneyoshi, N., & Nakatsuji, N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.135 · Cited by 300
HLA Typing and Its Influence on Organ Transplantation
Sheldon, S., & Poulton, K. (2006) · Humana Press eBooks · doi:10.1385/1-59745-049-9:157 · Cited by 130
Navarro, V. J., Herrine, S. K., Katopes, C., Colombe, B., & Spain, V. C. (2006) · Liver Transplantation · doi:10.1002/lt.20680 · Cited by 96
Multilineage Potential of Homozygous Stem Cells Derived from Metaphase II Oocytes
Lin, H. H., Lei, J., Wininger, D., Nguyen, M., Khanna, R., Hartmann, C., Yan, W., & Huang, S. C. (2003) · Stem Cells · doi:10.1634/stemcells.21-2-152 · Cited by 89
Genetic link between Asians and native Americans: evidence from HLA genes and haplotypes
Tokunaga, K., Ohashi, J., Bannai, M., & Juji, T. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00301-9 · Cited by 81
Kodera, Y., MORISHIMA, Y., Kato, S., Akiyama, Y., Sao, H., Matsuyama, T., Kawa, K., Sakamaki, H., Nakagawa, S., Hirabayashi, N., et al. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702027 · Cited by 70
Analysis of HLA haplotypes in Japanese, using high resolution allele typing
Nakajima, F., Nakamura, J., & Yokota, T. (2001) · Major Histocompatibility Complex · doi:10.12667/mhc.8.1 · Cited by 65
A Transcriptional Logic for Nuclear Reprogramming
Rodolfa, K. T., & Eggan, K. C. (2006) · Cell · doi:10.1016/j.cell.2006.08.009 · Cited by 46
Research works printed but not linked: 1
- Imanishi, 1992, HLA 1991, 76
Cited by
iPS cells: a game changer for future medicine
Inoue, H., Nagata, N., Kurokawa, H., & Yamanaka, S. (2014) · The EMBO Journal · doi:10.1002/embj.201387098 · Cited by 405
“One of the most feasible methods for iPSC therapy, therefore, will be based on the collection of iPSC stocks derived from various HLA-homozygous donors under Good Manufacturing Practice (GMP) compliance (Nakajima et al, 2007; Okita et al, 2011; Takahashi & Yamanaka, 2013).”
MethodHLA-haplotype banking and iPS cells
Nakatsuji, N., Nakajima, F., & Tokunaga, K. (2008) · Nature Biotechnology · doi:10.1038/nbt0708-739 · Cited by 336
Prospects for Stem Cell-Based Therapy
Daley, G. Q., & Scadden, D. T. (2008) · Cell · doi:10.1016/j.cell.2008.02.009 · Cited by 302
“A simulation performed within a Japanese cohort concluded that 100 homozygous donors could match 80% of the recipients (Nakajima et al., 2007).”
MethodGenomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
“Importantly, a small number of homozygous human leukocyte antigen (HLA) types could cover a large portion of populations [80, 81], making them ideal biological resources for allogeneic transplantation [79].”
BackgroundInduced pluripotent stem cells in medicine and biology
Takahashi, K., & Yamanaka, S. (2013) · Development · doi:10.1242/dev.092551 · Cited by 265
“Thus, at present, the most realistic method for iPSC therapy is based on the collection of iPSC stocks derived from various HLA-homozygous donors (Nakajima et al., 2007; Okita et al., 2011).”
Method
Metadata
- Authors
- Nakajima, F., Tokunaga, K., & Nakatsuji, N.
- Affiliations
- Japanese Red Cross Society, Japan (JP)
- The University of Tokyo (JP)
- Kyoto University (JP)
- Corresponding author
- Tokunaga, Katsushi
- Nakatsuji, Norio
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-12-21
- Volume
- 25
- Issue
- 4
- Pages
- 983-985
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2093267077
- Cited by
- 168
- References
- 15
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 4 · 2022: 11 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 13 · 2015: 14 · 2014: 12 · 2013: 10 · 2012: 19
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- human embryonic stem cell lines, HLA matching, HLA typing, stem cell banking, allogeneic cell transplantation, immunosuppression, HLA-A, HLA-B, HLA-DR, parthenogenetic embryos, Japanese population, ethnic diversity, donor availability
- MeSH terms
- Cell Line, Family, Female, Histocompatibility Testing, HLA Antigens, Humans, Japan, Male, Parthenogenesis, Tissue Banks, Stem Cell Transplantation, Cord Blood Stem Cell Transplantation, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.